Wendy N. Erber
- Genetics top 0.05%
- Hematology top 0.1%
- Molecular Biology top 1%
- Rheumatology top 0.2%
- Oncology top 1%
- Co-authors
- Anthony R. GreenKaren PulfordH. SteinBrunangelo FaliniLinda M. ScottJ L CordellS.M. MacDonaldD Y Mason
- Topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers)Acute Myeloid Leukemia Research (35 papers)Lymphoma Diagnosis and Treatment (22 papers)
- Cited by
- GeneticsHematologyRheumatology
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Wendy N. Erber
182 papers receiving 11.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Genetics 6.2k
- Hematology 5.0k
- Molecular Biology 4.8k
- Rheumatology 2.4k
- Oncology 2.0k
Countries citing papers authored by Wendy N. Erber
This map shows the geographic impact of Wendy N. Erber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy N. Erber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy N. Erber more than expected).
Fields of papers citing papers by Wendy N. Erber
This network shows the impact of papers produced by Wendy N. Erber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy N. Erber. The network helps show where Wendy N. Erber may publish in the future.
Co-authorship network of co-authors of Wendy N. Erber
This figure shows the co-authorship network connecting the top 25 collaborators of Wendy N. Erber. A scholar is included among the top collaborators of Wendy N. Erber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy N. Erber. Wendy N. Erber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 19 | |
| 8 | 20 | |
| 9 | 1 | |
| 10 | 7 | |
| 11 | DETECTION OF CHROMOSOMAL ABERRATIONS ASSOCIATED WITH PROGNOSIS OF UVEAL MELANOMA USING CIRCULATING TUMOUR CELLS | 1 |
| 12 | 5 | |
| 13 | 24 | |
| 14 | 20 | |
| 15 | 61 | |
| 16 | JAK2 exon 12 mutations occur frequently in idiopathic erythrocytosis patients with low serum erythropoietin levels | 1 |
| 17 | 473 | |
| 18 | 27 | |
| 19 | 41 | |
| 20 | 29 |
About Wendy N. Erber
Wendy N. Erber is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 186 papers that have together received 12.2k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers), Acute Myeloid Leukemia Research (35 papers) and Lymphoma Diagnosis and Treatment (22 papers). The work is most often cited by research in Genetics (6.2k citations), Hematology (5.0k citations) and Rheumatology (2.4k citations). Wendy N. Erber has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Anthony R. Green, Karen Pulford, H. Stein, Brunangelo Falini, Linda M. Scott, J L Cordell, S.M. MacDonald, D Y Mason, A K Ghosh and Peter J. Campbell. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.